Don't lose sight of age-related macular degeneration: The need for increased awareness in Singapore

Singapore Medical Journal

Volumn 49, Issue 11, 2008, Pages 850-853

  Woo, Jyh Haur ^a   Au Eong, K G ^b  

^a ALEXANDRA HOSPITAL   (Singapore)

^b MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; MINERAL; PLACEBO; VASCULOTROPIN; VITAMIN;

BLINDNESS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; EDITORIAL; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; LIFE EXPECTANCY; PHOTODYNAMIC THERAPY; PREVALENCE; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SINGAPORE; VISUAL ACUITY; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

BLINDNESS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MACULAR DEGENERATION; PATIENT EDUCATION AS TOPIC; RISK FACTORS; SINGAPORE;

EID: 57149110242     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (46)

1. Magnitude and causes of visual impairment. Geneva: World Health Organization; 2004 Nov. Fact sheet no: 282 [online]. Available at: www.who.int/mediacentre/factsheets/fs282/en/index.html. Accessed November 11, 2007.
2. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844-51.
3. Bressler NM, Bressler SB, Congdon NG, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 2003; 121:1621-4.
4. Klein R, Peto T, Bird A, et al. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137: 486-95.
5. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998; 116:514-20.
6. Owsley C, Sloane ME. Contrast sensitivity, acuity, and the perception of 'real-world' targets. Br J Ophthalmol 1987; 71:791-6.
7. Owsley C, McGwin G Jr, Sloane ME, Stalvey BT, Wells J. Timed instrumental activities of daily living tasks: relationship to visual function in older adults. Optom Vis Sci 2001; 78:350-9.
8. Klein BE, Klein R, Lee KE, Cruickshanks KJ. Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology 1998; 105:160-4.
9. Klein BE, Moss SE, Klein R, Lee KE, Cruickshanks KJ. Associations of visual function with physical outcomes and limitations 5 years later in an older population: the Beaver Dam eye study. Ophthalmology 2003; 110:644-50.
10. Miskala PH, Hawkins BS, Mangione CM, et al. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization-SST Report no: 1. Arch Ophthalmol 2003; 121:531-9.
11. Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol 1999; 128:45-53.
12. Brown MM, Brown GC, Sharma S, et al. The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol 2006; 17:257-66.
13. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001; 108:1893-900.
14. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol 2002; 120:1041-4.
15. Rovner BW, Casten RJ, Hegel MT, Hauck WW, Tasman WS. Dissatisfaction with performance of valued activities predicts depression in age-related macular degeneration. Int J Geriatr Psychiatry 2007; 22:789-93.
16. Rovner BW, Casten RJ. Activity loss and depression in age-related macular degeneration. Am J Geriatr Psychiatry 2002; 10:305-10.
17. Smiddy WE. Relative cost of a line of vision in age-related macular degeneration. Ophthalmology 2007; 114:847-54.
18. Eye Diseases Prevalence Research Group. Prevalence of age related macular degeneration in the United States. Arch Ophthalmol 2004; 122:564-72.
19. Vision problems in the U.S. Prevalence of adult vision impairment and age-related eye disease in America. Schaumburg, IL: Prevent Blindness America; 2002: 18-20. Available at: www.preventblindness.org/vpus/vp_contents.html. Accessed August 9, 2007.
20. Coleman AL, Yu F. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999. Ophthalmology 2008; 115: 18-25.
21. Bonastre J, Le Pen C, Anderson P, et al. The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom. Eur J Health Econ 2002; 3:94-102.
22. Low C H, Ho S H, Chong J. The impact of affluence on the major causes of blindness in Singapore over four decades. Asia Pac J Ophthalmol 1990; 2:418-21.
23. Singapore Association of the Visually Handicapped. Annual Report 2005/2006. Singapore: Singapore Association of the Visually Handicapped.
24. See JL, Wong TY, Yeo KT. Trends in the pattern of blindness and major ocular diseases in Singapore and Asia. Ann Acad Med Singapore 1998; 27:540-6.
25. Ho T, Law NM, Goh LG, Yoong T. Eye diseases in the elderly in Singapore. Singapore Med J 1997; 38:149-55.
26. Garraway WM, Whisnant JP. The changing pattern of hypertension and the declining incidence of stroke. JAMA 1987; 258:214-7.
27. Worden JK, Solomon LJ, Flynn BS, et al. A community-wide program in breast self-examination training and maintenance. Prev Med 1990; 19:254-69.
28. Awareness of a leading cause of blindness low among Singaporeans. Med Trib 2006 Oct 10: iv (col 4).
29. AMD Alliance International. Awareness of age-related macular degeneration and associated risk factors. AMD Global Report 2005. Toronto: AMD Alliance International, 2005.
30. Lau JT, Lee V, Fan D, Lau M, Michon J. Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population. Br J Ophthalmol 2002; 86:1080-4.
31. Winyard S, McLaughlan B. Awareness of age-related macular degeneration - using cross-national surveys to measure changes over time. International Congress Series 1282, 2005: 418-22.
32. Wagle AM, Yeo TK, Au Eong KG. Age-related macular degeneration: don't lose sight of possible prevention. (Letter) Lancet 2007; 370:1481.
33. Handa S, Au Eong KG. Time to raise awareness of blindness as another smoking-related condition. (Letter) Ann Acad Med Singapore 2006; 35:379-80.
34. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003; 48:257-93.
35. Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 2002; 120:1357-63.
36. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114:1518-23.
37. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996; 276:1147-51.
38. AMD Alliance International [online]. Available at: www.amdalliance.org. Accessed November 11, 2007.
39. Age-Related Eye Disease Study Research Group. A randomised, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for AMD and vision loss. AREDS report no: 8. Arch Ophthalmol 2001; 119:1417-36.
40. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994: 330:1029-35.
41. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150-55.
42. Brody BL, Roch-Levecq AC, Gamst AC, et al. Self-management of age-related macular degeneration and quality of life: a randomized controlled trial. Arch Ophthalmol 2002; 120:1477-83.
43. Au Eong KG, Yip CC. Prevention of blindness in Singapore: No room for complacency. Ann Acad Med Singapore 2007; 36 suppl:13-5.
44. Müller A, Keeffe JE, Taylor HR. Changes in eye care utilization following an eye health promotion campaign. Clin Experiment Ophthalmol 2007; 35:305-9.
45. Ng D, Sangtam T, Au Eong KG. The emerging challenge of age-related eye diseases in Singapore. Ann Acad Med Singapore 2007; 36 suppl:9-14.
46. Au Eong KG. Age-related macular degeneration: an emerging challenge for eye care and public health professionals in the Asia Pacific region. Ann Acad Med Singapore 2006; 35:133-5.